Koers L&K Biomed Ltd.
Aandelen
A156100
KR7156100000
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9.800 KRW | -0,10% | -1,80% | -3,73% |
1 week | -1,80% | ||
Lopende maand | -1,80% |
Omzet 2024 * | 61,2 mld. 44,37 mln. 41,13 mln. | Omzet 2025 * | 94,5 mld. 68,51 mln. 63,5 mln. | Marktkapitalisatie | 195 mld. 142 mln. 131 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 9 mld. 6,52 mln. 6,05 mln. | Nettowinst (verlies) 2025 * | 19 mld. 13,77 mln. 12,77 mln. | EV/omzet 2024 * | 3,31 x |
Nettoschuld 2024 * | 7,4 mld. 5,36 mln. 4,97 mln. | Nettoliquiditeiten 2025 * | 9 mld. 6,52 mln. 6,05 mln. | EV/omzet 2025 * | 1,97 x |
K/w-verhouding 2024 * |
21,3
x | K/w-verhouding 2025 * |
10,1
x | Werknemers | 60 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 86,87% |
1 dag | -0,10% | ||
1 week | -1,80% | ||
Lopende maand | -1,80% | ||
1 maand | +8,17% | ||
3 maanden | +32,79% | ||
6 maanden | +16,53% | ||
Lopend jaar | -3,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Geun-Ju Park
CEO | Chief Executive Officer | 60 | 01-12-19 |
Gook-Jin Kang
CEO | Chief Executive Officer | 57 | 01-12-08 |
Hee-Bok Shin
AUD | Comptroller/Controller/Auditor | 53 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gook-Jin Kang
CEO | Chief Executive Officer | 57 | 01-12-08 |
Director/Board Member | 67 | - | |
Geun-Ju Park
CEO | Chief Executive Officer | 60 | 01-12-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
07-06-24 | 9.800 | -0,10% | 60 008 |
05-06-24 | 9.810 | -2,78% | 124 801 |
04-06-24 | 10.090 | +0,20% | 67 608 |
03-06-24 | 10.070 | +0,90% | 105 302 |
31-05-24 | 9.980 | -2,16% | 102 026 |
slotkoers Korea S.E., 07 juni 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,73% | 143 mln. | |
-3,76% | 11,53 mld. | |
-4,86% | 8,33 mld. | |
+43,30% | 5,74 mld. | |
-22,44% | 4,65 mld. | |
+7,79% | 3,42 mld. | |
-17,26% | 2,63 mld. | |
-13,36% | 2,05 mld. | |
-16,39% | 1,9 mld. | |
-31,24% | 1,59 mld. |